NewAmsterdam Pharma Company N.V. Share Price & Technical Analysis
NAMS · $35.44 (-0.84%)
Healthcare / Biotechnology
$35.44
-0.84%
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular disease…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
23% return in May, -8% avg return in past 3 year May month.
6% return in 2026, 52% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -12% | 15% | -8% | -12% | 23% | – | – | – | – | – | – | – | 6% |
| 25 | -13% | -4% | -3% | -5% | -7% | -1% | 21% | 12% | 18% | 33% | 10% | -15% | 46% |
| 24 | 83% | 11% | 2% | -8% | -14% | 0% | -12% | -4% | 2% | 8% | 16% | 29% | 113% |
| 23 | 24% | -5% | 1% | 5% | -4% | -16% | -4% | -12% | -11% | 0% | 4% | 14% | -4% |
| 22 | 0% | 0% | 0% | 1% | 0% | 1% | 0% | 0% | 1% | 1% | -19% | 38% | 23% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.59B
P/E ratio
—
52W high
$42.20
52W low
$16.79
Volume
5,65,191
Beta
0.03
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is NewAmsterdam Pharma Company N.V. share price today?
- NewAmsterdam Pharma Company N.V. (NAMS) last traded around $35.44 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NAMS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NAMS. Download the app for real-time alerts.
- How can I analyze NewAmsterdam Pharma Company N.V. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.